中华中医药学刊2025，Vol.43Issue(5)：251-258,8.DOI:10.13193/j.issn.1673-7717.2025.05.048
疏血通注射液治疗缺血性脑血管病临床应用专家共识
Expert Consensus on Clinical Application of Shuxuetong Injection(疏血通注射液)in Treatment of Ischemic Cerebrovascular Disease
摘要
Abstract
Shuxuetong Injection(疏血通注射液)promotes blood circulation,removes blood stasis and activates channels and collaterals.It is primarily used during the acute phase of ischemic stroke caused by blood stasis obstructing the meridians and col-laterals,with demonstrated clinical efficacy and safety.This consensus adheres to the compilation process of the expert consensus on the clinical application of Chinese patent medicines by the Chinese Association of Traditional Chinese Medicine,following the principle of evidence-based medicine as the mainstay,supplemented by consensus and experience.It integrates the best availa-ble evidence with expert experience in real-world clinical practice,collecting clinical application recommendations through ques-tionnaire surveys and expert interviews,identifying clinical questions based on the PICOS principle,and conducting evidence eval-uation and GRADE grading.Through the nominal group method,seven recommendations(including three strong and four weak recommendations)and 23 consensus suggestions were formed,addressing the indications,timing of administration,dosage and treatment course of Shuxuetong Injection.This update also enhances safety information and revises the pharmacological and toxico-logical content of the first edition of the Expert Consensus on the Clinical Application of Shuxuetong Injection in the Treatment of Is-chemic Cerebrovascular Diseases,providing a reference for the rational clinical use of Shuxuetong Injection.This consensus has been reviewed and published by the Chinese Association of Traditional Chinese Medicine(document number GS/CACM345-2024).关键词
缺血性脑血管病/疏血通注射液/专家共识/证据/临床问题Key words
ischemic cerebrovascular disease/Shuxuetong Injection(疏血通注射液)/expert consensus on clinical applica-tion/evidence/clinical issues分类
医药卫生引用本文复制引用
唐璐,马丽芳,史华伟,赵性泉,高颖,《疏血通注射液治疗缺血性脑血管病临床应用专家共识》项目组..疏血通注射液治疗缺血性脑血管病临床应用专家共识[J].中华中医药学刊,2025,43(5):251-258,8.基金项目
中华中医药学会《疏血通注射液治疗缺血性脑血管病临床应用专家共识》项目(GS/CACM345-2024) （GS/CACM345-2024）
